SlideShare a Scribd company logo
1 of 28
Highlights from ExLPharma’s 2nd Pharmaceutical Managed Markets Insight  and Marketing February 9-10, 2010 Philadelphia, PA
The Providers Perspective
Provider’s Concerns Quality of Care Patients Access to Drugs Compliance/Costs of Readmits or unnecessary ER visits  Free up Capacity Reduce Denials Getting Paid
What can you do? Keep us informed of expensive drugs and how do we get paid.
			ExampleCoverage for Drug X in Local Market
Convince the Medical Directors of Health Plans Instead of just paying for one drug among a whole class of drugs, focus on patient-centered care Help to finance for “Off-label” use if justified  Streamline Charity Care Guidelines
Bottom-line: Everyone Wins Patients – gain access to drugs for individualized treatment Insurers - May pay more for drugs which will more than off-set by avoiding unnecessary ER visits, readmits and patient compliance.  Hospitals – Provide quality care to patients & actually get paid
And YOU? More Sales
Keys to Developing a Medical/Value Managed Care Strategy to Achieve Competitive Advantage
10 The Evidence Continuum  APPLICATION OF EVIDENCE-BASED MEDICINE  Population  Based    Local & Customized EVIDENCE GENERATION EVIDENCE TRANSLATION EVIDENCE APPLICATION Safety Efficacy Effectiveness Efficiency Proof of Concept Tolerability Best Value ?  Risk /Benefit ? Real World Benefits ? CONTROLLED CLINICAL STUDIES REAL WORLD STUDIES Process Improvement  & Quality of Care Initiatives  Practical Clinical Trials Quasi Experimental Studies Observational Studies Economic / Cost / Utility Studies  Systematic Reviews  Population Management Programs Quality of Care Initiatives Point of Care Decision Support Consumer-Centric / Directed Care  Placebo Comparator Agent  Comparators Rigor  Generalizability
Supporting the Evidence Continuum   Evidence Gap: ,[object Object]
 Market & Customer Insights
 Coverage & Reimbursement Decision MakingEvidence                 Generation: Safety, Efficacy &  Real World  Effectiveness   Research to support  product value                 proposition Evidence      Translation: Development  of Customer Centric  “Toolbox” to support   Access , Coverage  & Process  of Care Activities   Evidence     Application: Customized Solutions  to support Preferred & Appropriate Utilization of Portfolio
Evolving Customer Needs Evolving Customer Needs Traditional Customer Needs Evidence-Based Medicine Broad Business Acumen Ability to Lead Transformation Clinically Effective, Safe, and Tolerable 1.Cost Effective 2.Improves Quality 3.Easy to Adopt 1. Clinically Effective, Safe, and Tolerable 2. Cost Effective 3. Improves Quality 4. Easy to Adopt Adapting to an Evolving Customer Environment
Customized Solutions Approach A P P L Y Population- Based Evidence- Based Local and Plan Level- Based Measurement-Based T O Identify and treat appropriate patients Promote evidence-based best practices Improve patient outcome and quality of life Manage total cost of care D E L I V E R   V A L U E
Redefining the Value Equation What is it?• Efficacy• Safety• Tolerability• Clinical trials Who else thinks it’s valuable?• Thought leader support• Patient organization support• Healthcare provider advocacy• Quality organization support Clinical Profile  Influence Plan Net Cost Related Value What’s in it for me?• Outcomes • Cost effectiveness• Cost offsets• Quality improvement How much will it cost?• Discounts• Rebates ,[object Object]
Historically underutilized
Changes the value equation,[object Object]
Evidence Translation Toolbox  Knowledge Transfer Population Health Support  Point of Care Support    ,[object Object]
Monographs
Slide Presentations
Dossiers
Compendia
EB Synthesis
CME programs
Advocacy Meetings
Product Information
Budget Impact Models

More Related Content

What's hot

PEMM Overview Presentation
PEMM Overview PresentationPEMM Overview Presentation
PEMM Overview PresentationPerficient, Inc.
 
Patient centric care
Patient centric carePatient centric care
Patient centric careInnovaccer
 
Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5Greg Bauer
 
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Parata Systems
 
Sep oct 2012 partners press-ganey
Sep oct 2012 partners press-ganeySep oct 2012 partners press-ganey
Sep oct 2012 partners press-ganeyBradKruger
 
Deloitte innovacion health
Deloitte innovacion healthDeloitte innovacion health
Deloitte innovacion healthgbra80
 
The Future of Personalizing Care Management & the Patient Experience
The Future of Personalizing Care Management & the Patient ExperienceThe Future of Personalizing Care Management & the Patient Experience
The Future of Personalizing Care Management & the Patient ExperienceRaphael Louis Vitón
 
Better care at less cost - a 'how to' for commissioners and providers, pop up...
Better care at less cost - a 'how to' for commissioners and providers, pop up...Better care at less cost - a 'how to' for commissioners and providers, pop up...
Better care at less cost - a 'how to' for commissioners and providers, pop up...NHS England
 
Creating value beyond the pill
Creating value beyond the pillCreating value beyond the pill
Creating value beyond the pillexecutiveinsight
 
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...Building Patient-Centeredness in the Real World: The Engaged Patient and the ...
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...EngagingPatients
 
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015Arda Ural, MSc, MBA, PhD
 
Automating ED Patient Follow-Up: INFOGRAPHIC
Automating ED Patient Follow-Up: INFOGRAPHICAutomating ED Patient Follow-Up: INFOGRAPHIC
Automating ED Patient Follow-Up: INFOGRAPHICEngagingPatients
 
The Powerful and Evolving Role of Patient Advocacy Groups in Orphan Drug Deve...
The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...
The Powerful and Evolving Role of Patient Advocacy Groups in Orphan Drug Deve...PremierResearch_
 
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
 
Fda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivFda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivNathan White, CPC
 
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715Karin Jork-Wellbrock
 
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's RoleTodd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's RoleTodd Berner MD
 
Medical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryMedical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryBest Practices, LLC
 
The Population Health Management Market 2015
The Population Health Management Market 2015The Population Health Management Market 2015
The Population Health Management Market 2015Lifelog Health
 

What's hot (20)

PEMM Overview Presentation
PEMM Overview PresentationPEMM Overview Presentation
PEMM Overview Presentation
 
Vertelogics MR.ES
Vertelogics MR.ESVertelogics MR.ES
Vertelogics MR.ES
 
Patient centric care
Patient centric carePatient centric care
Patient centric care
 
Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5Delivering value based_care_with_e_health_services.5
Delivering value based_care_with_e_health_services.5
 
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)
 
Sep oct 2012 partners press-ganey
Sep oct 2012 partners press-ganeySep oct 2012 partners press-ganey
Sep oct 2012 partners press-ganey
 
Deloitte innovacion health
Deloitte innovacion healthDeloitte innovacion health
Deloitte innovacion health
 
The Future of Personalizing Care Management & the Patient Experience
The Future of Personalizing Care Management & the Patient ExperienceThe Future of Personalizing Care Management & the Patient Experience
The Future of Personalizing Care Management & the Patient Experience
 
Better care at less cost - a 'how to' for commissioners and providers, pop up...
Better care at less cost - a 'how to' for commissioners and providers, pop up...Better care at less cost - a 'how to' for commissioners and providers, pop up...
Better care at less cost - a 'how to' for commissioners and providers, pop up...
 
Creating value beyond the pill
Creating value beyond the pillCreating value beyond the pill
Creating value beyond the pill
 
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...Building Patient-Centeredness in the Real World: The Engaged Patient and the ...
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...
 
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
 
Automating ED Patient Follow-Up: INFOGRAPHIC
Automating ED Patient Follow-Up: INFOGRAPHICAutomating ED Patient Follow-Up: INFOGRAPHIC
Automating ED Patient Follow-Up: INFOGRAPHIC
 
The Powerful and Evolving Role of Patient Advocacy Groups in Orphan Drug Deve...
The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...
The Powerful and Evolving Role of Patient Advocacy Groups in Orphan Drug Deve...
 
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...
 
Fda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivFda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In Ventiv
 
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
 
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's RoleTodd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's Role
 
Medical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report SummaryMedical Affairs Resources, Structures, and Trends Report Summary
Medical Affairs Resources, Structures, and Trends Report Summary
 
The Population Health Management Market 2015
The Population Health Management Market 2015The Population Health Management Market 2015
The Population Health Management Market 2015
 

Viewers also liked

Top work capitolo 2
Top work capitolo 2Top work capitolo 2
Top work capitolo 2Etikalab
 
Raona - Web pública con SharePoint 2010
Raona - Web pública con SharePoint 2010Raona - Web pública con SharePoint 2010
Raona - Web pública con SharePoint 2010Raona
 
First Street Corridor Final
First Street Corridor FinalFirst Street Corridor Final
First Street Corridor Finalmrizzit2
 
What's New in RTView Core 6.5
What's New in RTView Core 6.5 What's New in RTView Core 6.5
What's New in RTView Core 6.5 SL Corporation
 
2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina
2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina
2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North CarolinaCourtney Boone
 
My self lilia
My self liliaMy self lilia
My self lilia18tanli
 
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...ExL Pharma
 
October 15 speech and writing
October 15 speech and writingOctober 15 speech and writing
October 15 speech and writingJessica Visseau
 
A good time is blog time
A good time is blog timeA good time is blog time
A good time is blog timePatty009
 
Jobbprofil bussjåfør
Jobbprofil bussjåførJobbprofil bussjåfør
Jobbprofil bussjåføringerikt
 
It健康
It健康It健康
It健康baidu
 
Analisisbab4 pencapaian
Analisisbab4 pencapaianAnalisisbab4 pencapaian
Analisisbab4 pencapaiansiti mizarina
 
SkyDrive
SkyDriveSkyDrive
SkyDrivemaricel
 
Growth And Capital Flows With Risky Entrepreneurship
Growth And Capital Flows With Risky EntrepreneurshipGrowth And Capital Flows With Risky Entrepreneurship
Growth And Capital Flows With Risky EntrepreneurshipVladimir Gidirim
 
Issues in nursing
Issues in nursingIssues in nursing
Issues in nursinggracemae
 
Presentation1
Presentation1Presentation1
Presentation1lienad25
 

Viewers also liked (20)

Hoe Werkt Twiter Zakelijk?
Hoe Werkt Twiter Zakelijk? Hoe Werkt Twiter Zakelijk?
Hoe Werkt Twiter Zakelijk?
 
Top work capitolo 2
Top work capitolo 2Top work capitolo 2
Top work capitolo 2
 
Raona - Web pública con SharePoint 2010
Raona - Web pública con SharePoint 2010Raona - Web pública con SharePoint 2010
Raona - Web pública con SharePoint 2010
 
First Street Corridor Final
First Street Corridor FinalFirst Street Corridor Final
First Street Corridor Final
 
What's New in RTView Core 6.5
What's New in RTView Core 6.5 What's New in RTView Core 6.5
What's New in RTView Core 6.5
 
2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina
2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina
2011 Eclipse For Sale at Keffer Mitsubishi, Charlotte North Carolina
 
My self lilia
My self liliaMy self lilia
My self lilia
 
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
 
October 15 speech and writing
October 15 speech and writingOctober 15 speech and writing
October 15 speech and writing
 
台灣住宅法與住宅政策簡介
台灣住宅法與住宅政策簡介台灣住宅法與住宅政策簡介
台灣住宅法與住宅政策簡介
 
A good time is blog time
A good time is blog timeA good time is blog time
A good time is blog time
 
Jobbprofil bussjåfør
Jobbprofil bussjåførJobbprofil bussjåfør
Jobbprofil bussjåfør
 
Partes de una carta
Partes de una cartaPartes de una carta
Partes de una carta
 
It健康
It健康It健康
It健康
 
Analisisbab4 pencapaian
Analisisbab4 pencapaianAnalisisbab4 pencapaian
Analisisbab4 pencapaian
 
SkyDrive
SkyDriveSkyDrive
SkyDrive
 
Growth And Capital Flows With Risky Entrepreneurship
Growth And Capital Flows With Risky EntrepreneurshipGrowth And Capital Flows With Risky Entrepreneurship
Growth And Capital Flows With Risky Entrepreneurship
 
Issues in nursing
Issues in nursingIssues in nursing
Issues in nursing
 
Presentation1
Presentation1Presentation1
Presentation1
 
Syllabus comm 3190 01.spring 2012
Syllabus comm 3190 01.spring 2012Syllabus comm 3190 01.spring 2012
Syllabus comm 3190 01.spring 2012
 

Similar to Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets

Harness Your Clinical and Financial Data with an Enterprise Health Informat...
Harness Your Clinical and Financial Data with an Enterprise Health Informat...Harness Your Clinical and Financial Data with an Enterprise Health Informat...
Harness Your Clinical and Financial Data with an Enterprise Health Informat...Perficient, Inc.
 
Harnessing Population Health Management to Promote Quality Improvement in Hea...
Harnessing Population Health Management to Promote Quality Improvement in Hea...Harnessing Population Health Management to Promote Quality Improvement in Hea...
Harnessing Population Health Management to Promote Quality Improvement in Hea...Queena Deschene, RCFE
 
Primary Care Enterpreneurship models.pdf
Primary Care Enterpreneurship models.pdfPrimary Care Enterpreneurship models.pdf
Primary Care Enterpreneurship models.pdfsachinganorkar1
 
Daniel Jackson, UCB
Daniel Jackson, UCBDaniel Jackson, UCB
Daniel Jackson, UCBGoPrezi
 
Quest for Value Deloitte
Quest for Value DeloitteQuest for Value Deloitte
Quest for Value Deloittekdexpressible
 
Market Access 101: Connecting Access Challenges to Brand Opportunities
Market Access 101: Connecting Access Challenges to Brand OpportunitiesMarket Access 101: Connecting Access Challenges to Brand Opportunities
Market Access 101: Connecting Access Challenges to Brand OpportunitiesOgilvy Health
 
Demonstrating the Value of Child Life Services in a Changing Health Care Envi...
Demonstrating the Value of Child Life Services in a Changing Health Care Envi...Demonstrating the Value of Child Life Services in a Changing Health Care Envi...
Demonstrating the Value of Child Life Services in a Changing Health Care Envi...TCHChildLifeConference
 
Value of Personalized Health Care
Value of Personalized Health CareValue of Personalized Health Care
Value of Personalized Health CareRyan Squire
 
US Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docx
US Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docxUS Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docx
US Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docxdickonsondorris
 
Ohio may 14 2011
Ohio may 14 2011 Ohio may 14 2011
Ohio may 14 2011 Paul Grundy
 
Cortese/Korsmo Presentation
Cortese/Korsmo PresentationCortese/Korsmo Presentation
Cortese/Korsmo PresentationLee Aase
 
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007A.R.J. (Rob) Halkes
 
Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...
Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...
Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...ExL Pharma
 
Anne Bracken Univ of South AL - aco rural health
Anne Bracken   Univ of South AL - aco rural healthAnne Bracken   Univ of South AL - aco rural health
Anne Bracken Univ of South AL - aco rural healthSamantha Haas
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyJim Fisher
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyJim Fisher
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyJim Fisher
 

Similar to Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets (20)

Harness Your Clinical and Financial Data with an Enterprise Health Informat...
Harness Your Clinical and Financial Data with an Enterprise Health Informat...Harness Your Clinical and Financial Data with an Enterprise Health Informat...
Harness Your Clinical and Financial Data with an Enterprise Health Informat...
 
Harnessing Population Health Management to Promote Quality Improvement in Hea...
Harnessing Population Health Management to Promote Quality Improvement in Hea...Harnessing Population Health Management to Promote Quality Improvement in Hea...
Harnessing Population Health Management to Promote Quality Improvement in Hea...
 
Primary Care Enterpreneurship models.pdf
Primary Care Enterpreneurship models.pdfPrimary Care Enterpreneurship models.pdf
Primary Care Enterpreneurship models.pdf
 
Daniel Jackson, UCB
Daniel Jackson, UCBDaniel Jackson, UCB
Daniel Jackson, UCB
 
Quest for Value Deloitte
Quest for Value DeloitteQuest for Value Deloitte
Quest for Value Deloitte
 
Market Access 101: Connecting Access Challenges to Brand Opportunities
Market Access 101: Connecting Access Challenges to Brand OpportunitiesMarket Access 101: Connecting Access Challenges to Brand Opportunities
Market Access 101: Connecting Access Challenges to Brand Opportunities
 
Demonstrating the Value of Child Life Services in a Changing Health Care Envi...
Demonstrating the Value of Child Life Services in a Changing Health Care Envi...Demonstrating the Value of Child Life Services in a Changing Health Care Envi...
Demonstrating the Value of Child Life Services in a Changing Health Care Envi...
 
Aware - Just Clinical
Aware - Just ClinicalAware - Just Clinical
Aware - Just Clinical
 
Value of Personalized Health Care
Value of Personalized Health CareValue of Personalized Health Care
Value of Personalized Health Care
 
US Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docx
US Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docxUS Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docx
US Healthcare Delivery SystemsQuality Outcome MeasuresDonna .docx
 
Ohio may 14 2011
Ohio may 14 2011 Ohio may 14 2011
Ohio may 14 2011
 
Globe Healer
Globe Healer Globe Healer
Globe Healer
 
Cortese/Korsmo Presentation
Cortese/Korsmo PresentationCortese/Korsmo Presentation
Cortese/Korsmo Presentation
 
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007
 
Webinar - Pharmacy Strategies for Purchasers
Webinar - Pharmacy Strategies for PurchasersWebinar - Pharmacy Strategies for Purchasers
Webinar - Pharmacy Strategies for Purchasers
 
Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...
Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...
Highlights from ExL Pharma's 6th Pharmaceutical & Medical Device Pricing & Re...
 
Anne Bracken Univ of South AL - aco rural health
Anne Bracken   Univ of South AL - aco rural healthAnne Bracken   Univ of South AL - aco rural health
Anne Bracken Univ of South AL - aco rural health
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copy
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copy
 
Accenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copyAccenture strategy-patient-engagement-consumer-loyalty - copy
Accenture strategy-patient-engagement-consumer-loyalty - copy
 

More from ExL Pharma

9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best PracticesExL Pharma
 
CMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, BostonCMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, BostonExL Pharma
 
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJExL Pharma
 
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VAExL Pharma
 
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyThe 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyExL Pharma
 
6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York CityExL Pharma
 
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...ExL Pharma
 
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, MiamiExL Pharma
 
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, PhiladelphiaExL Pharma
 
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...ExL Pharma
 
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, PhiladelphiaExL Pharma
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsExL Pharma
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceExL Pharma
 
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenHighlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenExL Pharma
 
Highlights from ExL Pharma's 2nd Digital Pharma Europe
Highlights from  ExL Pharma's 2nd Digital Pharma EuropeHighlights from  ExL Pharma's 2nd Digital Pharma Europe
Highlights from ExL Pharma's 2nd Digital Pharma EuropeExL Pharma
 
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceHighlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceExL Pharma
 
Highlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesHighlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesExL Pharma
 
Highlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationHighlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationExL Pharma
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical TrialsExL Pharma
 

More from ExL Pharma (20)

9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices
 
CMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, BostonCMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, Boston
 
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
 
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
 
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyThe 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
 
6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City
 
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
 
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
 
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
 
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
 
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best Practices
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP Compliance
 
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenHighlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
 
Highlights from ExL Pharma's 2nd Digital Pharma Europe
Highlights from  ExL Pharma's 2nd Digital Pharma EuropeHighlights from  ExL Pharma's 2nd Digital Pharma Europe
Highlights from ExL Pharma's 2nd Digital Pharma Europe
 
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceHighlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
 
Highlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesHighlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring Committees
 
Highlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationHighlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & Communication
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 

Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets

  • 1. Highlights from ExLPharma’s 2nd Pharmaceutical Managed Markets Insight and Marketing February 9-10, 2010 Philadelphia, PA
  • 3. Provider’s Concerns Quality of Care Patients Access to Drugs Compliance/Costs of Readmits or unnecessary ER visits Free up Capacity Reduce Denials Getting Paid
  • 4. What can you do? Keep us informed of expensive drugs and how do we get paid.
  • 5. ExampleCoverage for Drug X in Local Market
  • 6. Convince the Medical Directors of Health Plans Instead of just paying for one drug among a whole class of drugs, focus on patient-centered care Help to finance for “Off-label” use if justified Streamline Charity Care Guidelines
  • 7. Bottom-line: Everyone Wins Patients – gain access to drugs for individualized treatment Insurers - May pay more for drugs which will more than off-set by avoiding unnecessary ER visits, readmits and patient compliance. Hospitals – Provide quality care to patients & actually get paid
  • 9. Keys to Developing a Medical/Value Managed Care Strategy to Achieve Competitive Advantage
  • 10. 10 The Evidence Continuum APPLICATION OF EVIDENCE-BASED MEDICINE Population Based Local & Customized EVIDENCE GENERATION EVIDENCE TRANSLATION EVIDENCE APPLICATION Safety Efficacy Effectiveness Efficiency Proof of Concept Tolerability Best Value ? Risk /Benefit ? Real World Benefits ? CONTROLLED CLINICAL STUDIES REAL WORLD STUDIES Process Improvement & Quality of Care Initiatives Practical Clinical Trials Quasi Experimental Studies Observational Studies Economic / Cost / Utility Studies Systematic Reviews Population Management Programs Quality of Care Initiatives Point of Care Decision Support Consumer-Centric / Directed Care Placebo Comparator Agent Comparators Rigor Generalizability
  • 11.
  • 12. Market & Customer Insights
  • 13. Coverage & Reimbursement Decision MakingEvidence Generation: Safety, Efficacy & Real World Effectiveness Research to support product value proposition Evidence Translation: Development of Customer Centric “Toolbox” to support Access , Coverage & Process of Care Activities Evidence Application: Customized Solutions to support Preferred & Appropriate Utilization of Portfolio
  • 14. Evolving Customer Needs Evolving Customer Needs Traditional Customer Needs Evidence-Based Medicine Broad Business Acumen Ability to Lead Transformation Clinically Effective, Safe, and Tolerable 1.Cost Effective 2.Improves Quality 3.Easy to Adopt 1. Clinically Effective, Safe, and Tolerable 2. Cost Effective 3. Improves Quality 4. Easy to Adopt Adapting to an Evolving Customer Environment
  • 15. Customized Solutions Approach A P P L Y Population- Based Evidence- Based Local and Plan Level- Based Measurement-Based T O Identify and treat appropriate patients Promote evidence-based best practices Improve patient outcome and quality of life Manage total cost of care D E L I V E R V A L U E
  • 16.
  • 18.
  • 19.
  • 40. Pt Compliance Support
  • 41. Self Care Tools
  • 42. Case Mgmt Tools
  • 44. Pt Education Support
  • 46.
  • 47. Health Care Challenges—Are there solutions we can trust?
  • 48. The Ever Changing Landscape Increased price pressures Fewer new unique Chemical entities being brought to the FDA Fewer new Pharmaceutical products being approved Risk Evaluation Mitigation Programs (REMs) Increased pressures to demonstrate health outcomes Medication Adherence and Persistency Patient non-adherence causing costs to rise Politicians desiring to practice medicine Patient satisfaction/Customer service growing more uneasy
  • 49. Stake Holders searching For solutions Government Healthcare Reform Non-Government Collaborations The California Pay For Performance Program The California Healthcare Foundation (CHCF) The National Committee for Quality Assurance (NCQA) The Pacific Business Group on Health (PBGH) The California Association of Physician Groups (CAPG) Managed Care Organizations Pharmaceutical Manufacturers National Organizations Evidence-based clinical practice guidelines Value-based Benefit Designs Employers Patients Health Care Providers
  • 50. Searching for Solutions California’s Pay-For-Performance Program Non-governmental physician incentive program Improve quality of care and health outcomes 8 Health Plans 200 Medical Groups 35,000 Physicians caring for 11.5 Million HMO Members Single performance-based set of measures Public report card Aggregation of data from multiple payers for calculating scores Source: The California Pay for Performance Program, The Second Chapter, Measurement Years 2006-2009
  • 51. Searching for Solutions Patient-Centered Medical Homes Goal: “Relieve the looming crisis in primary care, improve clinical quality and patient experience, and moderate cost increases.” Coalition Major Employers Consumer Groups Patient Quality Organizations Health Plans Labor Unions Hospitals Physicians Source: www.pcpcc.net/content/pcmh-vision-reality
  • 52. Searching for Solutions PCMH continued Pilots in 44 States & District of Columbia Commercial Medicare Medicaid VA/DOD LTC
  • 53. Searching for Solutions Education Health Coaches Electronic Health Records Patient phone calls Automated Telephone Self Management Support Programs Stakeholder Alignments Health Insurance for everyone Removing soda pop from schools Make healthy foods available at a cheaper price Single Payer Health Care Government/Elected Officials Taxes on Soda Pop
  • 54. Searching for Solutions Put the healthcare dollar in the consumers hands Allow market forces to drive the delivery of Healthcare Real incentives to the consumer of healthcare Strategic Legislation Malpractice Insurance Reform Worker’s Compensation*** Reform Welfare System***
  • 55. Searching for Solutions Things to Consider: Government’s track record of Program implementation & sustainability “If you put the federal government in charge of the Sahara Desert, in 5 years there would be a shortage of sand.” Morgan Friedman The best of America comes when “These are that tries men’s souls” Thomas Paine “What we obtain too cheap, we esteem too lightly” Thomas Paine The Wizard is Fraud!! The entrepreneurial spirit is alive and well in America When incentives are appropriately aligned America’s citizens will rally and find ways to succeed ‘Rome was not built in a day and it did not fall in a day’
  • 56. There is no magic quick fix solution When we are sick we take sick days to heal ourselves or we go to the appropriate Physician—the Government doesn’t treat fevers
  • 57. Still have any questions? For additional information on ExLPharma’s Pharmaceutical Managed Markets Insight and Marketing Conferences, please visitwww.exlpharma.com